Przejdź do zawartości
· Wypełniacze skórne
SKU 11162 · GTIN 0107640173234784

Teosyal RHA 2

Dostępny
Objętość
2 x 1 mL
Laboratorium
Teoxane
Pochodzenie
Szwajcaria
Wskazanie
Facial wrinkle, volume and reconstructive correction
Cena hurtowa i historia tylko dla zweryfikowanych
allpara zaopatruje licencjonowanych specjalistów. Zaloguj się lub załóż konto B2B, aby zobaczyć aktualne ceny, progi ilościowe i historię cen.

TEOSYAL RHA 2 is a transparent, sterile, non-pyrogenic and viscoelastic hyaluronic acid filler of non-animal origin from Teoxane SA in Geneva, formulated to correct facial wrinkles and skin creases and to add volume to facial tissues. It is indicated across the upper face and the periorbital, midface and perioral regions. Its formula carries 23 mg/mL of BDDE cross-linked hyaluronic acid, at a mean molecular weight above 1 million Dalton, together with 0.3% by mass of lidocaine hydrochloride. The box contains two pre-filled syringes, each supplied with two sterile 30G 1/2 inch needles and two traceability labels.

Najważniejsze zalety: Teosyal RHA 2

  • Corrects facial wrinkles and skin creases and augments the volume of facial tissues
  • Covers four facial regions from one reference: upper face, periorbital, midface and perioral
  • Hyaluronic acid at 23 mg/mL with a degree of cross-linking below 5%
  • Mean molecular weight above 1 million Dalton, of non-animal origin, residual BDDE below 1 ppm
  • Contains lidocaine hydrochloride 0.3% by mass to reduce the sensation of pain
  • Two pre-filled syringes per box, each with two sterile 30G 1/2 inch needles and traceability labels
  • Estimated duration of 12 to 18 months
Najważniejsze informacje
Marka TEOSYAL
Producent Teoxane SA
Kraj pochodzenia Switzerland
Certyfikacja CE marked 2797 for the gel. The needles supplied are CE marked 0123 for TSK or 0197 for Terumo
Skład Hyaluronic acid of non-animal origin 23 mg/mL, cross-linked with BDDE (degree of cross-linking below 5%), at a mean molecular weight above 1 million Dalton; lidocaine hydrochloride 0.3% by mass; residual BDDE below 1 ppm; phosphate buffer pH 7.3 q.s. ad 1 mL
Objętość / Rozmiar 1 ml
Opakowanie 2 pre-filled syringes x 1 mL, each supplied with 2 sterile 30G 1/2 inch needles and 2 traceability labels; gel volume marked on the box and each syringe
Rodzaj zastosowania Professional use only - injectable dermal filler with anaesthetic, for facial wrinkles, volume augmentation and reconstructive indications
Głębokość iniekcji Injected slowly at variable depths depending on the area treated: into the dermis, subcutaneously, onto the supraperiosteum, or into the subdermis or the submucosa of the red lips. Must not be injected into the epidermis, into or close to a blood vessel, close to a nerve, or at depths other than those described
Protokół / Czas trwania Estimated lifetime of 12 to 18 months, depending on skin type, wrinkle severity, injection area, injected volume, and patient physiology and lifestyle

Wskazania i zastosowanie profesjonalne

Główne wskazania

  • Correction of any facial wrinkles and skin creases
  • Augmentation of the volume of facial tissues
  • Therapeutic indications: reconstructive surgery, filling of depressions due to scars, and reconstruction of volumes lost by lipoatrophy in patients undergoing HIV treatment

Zastosowanie profesjonalne

TEOSYAL RHA 2 is only to be administered by appropriately trained healthcare professionals who are qualified or accredited in accordance with national law, and is not for retail sale or self-administration. It is injected slowly at variable depths depending on the area treated: into the dermis, subcutaneously, onto the supraperiosteum, or into the subdermis or the submucosa of the red lips. It must not be injected into the epidermis, into or close to a blood vessel, close to a nerve, or at depths other than those described. Depending on the correction required, one or more treatment sessions or a touch-up may be needed to reach an optimal result.

Obszary zabiegowe

  • Upper face: forehead lines, forehead depression, glabellar lines, temples
  • Periorbital region: eyebrows and crow's feet
  • Midface: nasolabial folds, smiling lines and accordion lines
  • Perioral region: perioral rhytids, lips including the philtrum, marionette lines, oral commissures

Profil pacjenta

For adults assessed as suitable by the treating practitioner. It must not be used in patients with cutaneous disorders, inflammation or infection at or near the treatment site, since injection procedures can lead to reactivation of latent or subclinical herpes viral infection. It must also not be used in patients with a known hypersensitivity to hyaluronic acid with a history of severe allergy or anaphylactic shock, in patients with autoimmune diseases, or in pregnant or breastfeeding women. Because of the lidocaine content it must not be used in patients with known hypersensitivity to lidocaine or to amide local anaesthetics, in patients with cardiac diseases or undergoing treatment for heart disease (beta blockers), in patients with hepatocellular insufficiency or undergoing treatment for a liver disease, or in patients with epilepsy or porphyria. It must not be used in combination with other aesthetic procedures such as peeling, laser treatment or ultrasound-based treatment.

Jak działa Teosyal RHA 2 ​

TEOSYAL RHA 2 works through hyaluronic acid at 23 mg/mL with a degree of cross-linking below 5%. Hyaluronic acid is a major constituent of the ground substance of the dermal extracellular matrix and acts as a molecular sponge, binding water to restore volume where tissue has thinned. The low cross-linking relative to the concentration is what defines the RHA line: enough structure to correct a wrinkle or add tissue volume, while remaining adaptable in areas that move. It covers four facial regions.

Dlaczego warto zamawiać w Allpara

Allpara oferuje oryginalne, sprawdzone produkty TEOSYAL od zweryfikowanych dostawców, z pełną identyfikowalnością partii i wsparciem ekspertów. Obsługujemy kliniki i specjalistów medycyny estetycznej, oferując produkty z oznakowaniem CE, szybką dostawę na terenie całej UE z naszego magazynu w UE oraz konkurencyjne ceny hurtowe. Najważniejsze są dla nas bezpieczeństwo, satysfakcja i efekty Twoich pacjentów - z indywidualnym wsparciem posprzedażowym dla Twojego spokoju.

Najczęściej zadawane pytania

How does TEOSYAL RHA 2 differ from RHA 3?

Both carry 23 mg/mL hyaluronic acid with cross-linking below 5%, but they are placed differently. RHA 2 is for facial wrinkles and skin creases across the upper face, periorbital, midface and perioral regions, supplied with 30G needles. RHA 3 is for deep wrinkles and deep creases, adding volume in the midface and remodelling the lower face, supplied with 27G needles.

How long does TEOSYAL RHA 2 last?

The estimated in vivo lifetime is 12 to 18 months. Duration depends on skin type, the severity of the wrinkle treated, the injection area, the volume injected, and the patient's physiology and lifestyle.

Więcej od Teoxane

Zobacz laboratorium

Alternatywy dla kliniki

Wszystkie produkty

Teosyal RHA 2

Dostępny
Oznakowanie CE Oznakowanie CE Teosyal RHA 2
Ceny tylko dla zweryfikowanych
Zaloguj się lub załóż konto B2B, aby zobaczyć swoją cenę.
Konto B2B

TEOSYAL RHA 2 is a transparent, sterile, non-pyrogenic and viscoelastic hyaluronic acid filler of non-animal origin from Teoxane SA in Geneva, formulated to correct facial wrinkles and skin creases and to add volume to facial tissues. It is indicated across the upper face and the periorbital, midface and perioral regions. Its formula carries 23 mg/mL of BDDE cross-linked hyaluronic acid, at a mean molecular weight above 1 million Dalton, together with 0.3% by mass of lidocaine hydrochloride. The box contains two pre-filled syringes, each supplied with two sterile 30G 1/2 inch needles and two traceability labels.

Najważniejsze zalety: Teosyal RHA 2

  • Corrects facial wrinkles and skin creases and augments the volume of facial tissues
  • Covers four facial regions from one reference: upper face, periorbital, midface and perioral
  • Hyaluronic acid at 23 mg/mL with a degree of cross-linking below 5%
  • Mean molecular weight above 1 million Dalton, of non-animal origin, residual BDDE below 1 ppm
  • Contains lidocaine hydrochloride 0.3% by mass to reduce the sensation of pain
  • Two pre-filled syringes per box, each with two sterile 30G 1/2 inch needles and traceability labels
  • Estimated duration of 12 to 18 months
Najważniejsze informacje
Marka TEOSYAL
Producent Teoxane SA
Kraj pochodzenia Switzerland
Certyfikacja CE marked 2797 for the gel. The needles supplied are CE marked 0123 for TSK or 0197 for Terumo
Skład Hyaluronic acid of non-animal origin 23 mg/mL, cross-linked with BDDE (degree of cross-linking below 5%), at a mean molecular weight above 1 million Dalton; lidocaine hydrochloride 0.3% by mass; residual BDDE below 1 ppm; phosphate buffer pH 7.3 q.s. ad 1 mL
Objętość / Rozmiar 1 ml
Opakowanie 2 pre-filled syringes x 1 mL, each supplied with 2 sterile 30G 1/2 inch needles and 2 traceability labels; gel volume marked on the box and each syringe
Rodzaj zastosowania Professional use only - injectable dermal filler with anaesthetic, for facial wrinkles, volume augmentation and reconstructive indications
Głębokość iniekcji Injected slowly at variable depths depending on the area treated: into the dermis, subcutaneously, onto the supraperiosteum, or into the subdermis or the submucosa of the red lips. Must not be injected into the epidermis, into or close to a blood vessel, close to a nerve, or at depths other than those described
Protokół / Czas trwania Estimated lifetime of 12 to 18 months, depending on skin type, wrinkle severity, injection area, injected volume, and patient physiology and lifestyle

Wskazania i zastosowanie profesjonalne

Główne wskazania

  • Correction of any facial wrinkles and skin creases
  • Augmentation of the volume of facial tissues
  • Therapeutic indications: reconstructive surgery, filling of depressions due to scars, and reconstruction of volumes lost by lipoatrophy in patients undergoing HIV treatment

Zastosowanie profesjonalne

TEOSYAL RHA 2 is only to be administered by appropriately trained healthcare professionals who are qualified or accredited in accordance with national law, and is not for retail sale or self-administration. It is injected slowly at variable depths depending on the area treated: into the dermis, subcutaneously, onto the supraperiosteum, or into the subdermis or the submucosa of the red lips. It must not be injected into the epidermis, into or close to a blood vessel, close to a nerve, or at depths other than those described. Depending on the correction required, one or more treatment sessions or a touch-up may be needed to reach an optimal result.

Obszary zabiegowe

  • Upper face: forehead lines, forehead depression, glabellar lines, temples
  • Periorbital region: eyebrows and crow's feet
  • Midface: nasolabial folds, smiling lines and accordion lines
  • Perioral region: perioral rhytids, lips including the philtrum, marionette lines, oral commissures

Profil pacjenta

For adults assessed as suitable by the treating practitioner. It must not be used in patients with cutaneous disorders, inflammation or infection at or near the treatment site, since injection procedures can lead to reactivation of latent or subclinical herpes viral infection. It must also not be used in patients with a known hypersensitivity to hyaluronic acid with a history of severe allergy or anaphylactic shock, in patients with autoimmune diseases, or in pregnant or breastfeeding women. Because of the lidocaine content it must not be used in patients with known hypersensitivity to lidocaine or to amide local anaesthetics, in patients with cardiac diseases or undergoing treatment for heart disease (beta blockers), in patients with hepatocellular insufficiency or undergoing treatment for a liver disease, or in patients with epilepsy or porphyria. It must not be used in combination with other aesthetic procedures such as peeling, laser treatment or ultrasound-based treatment.

Jak działa Teosyal RHA 2 ​

TEOSYAL RHA 2 works through hyaluronic acid at 23 mg/mL with a degree of cross-linking below 5%. Hyaluronic acid is a major constituent of the ground substance of the dermal extracellular matrix and acts as a molecular sponge, binding water to restore volume where tissue has thinned. The low cross-linking relative to the concentration is what defines the RHA line: enough structure to correct a wrinkle or add tissue volume, while remaining adaptable in areas that move. It covers four facial regions.

Dlaczego warto zamawiać w Allpara

Allpara oferuje oryginalne, sprawdzone produkty TEOSYAL z pełną identyfikowalnością partii, produktami z oznakowaniem CE, szybką dostawą na terenie całej UE i fachowym wsparciem posprzedażowym.

Najczęściej zadawane pytania

How does TEOSYAL RHA 2 differ from RHA 3?

Both carry 23 mg/mL hyaluronic acid with cross-linking below 5%, but they are placed differently. RHA 2 is for facial wrinkles and skin creases across the upper face, periorbital, midface and perioral regions, supplied with 30G needles. RHA 3 is for deep wrinkles and deep creases, adding volume in the midface and remodelling the lower face, supplied with 27G needles.

How long does TEOSYAL RHA 2 last?

The estimated in vivo lifetime is 12 to 18 months. Duration depends on skin type, the severity of the wrinkle treated, the injection area, the volume injected, and the patient's physiology and lifestyle.

Więcej od Teoxane

Zobacz laboratorium →
* Produkt do użytku profesjonalnego. Opakowanie może się różnić w zależności od partii lub rynku. Pełne zalecenia i przeciwwskazania znajdziesz w dołączonej instrukcji użycia (IFU).